Daniel Morillo Giles
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Blood groups and transfusion
-
- CAR-T cell therapy research
Papers in
- Hematology 12
- Multiple Myeloma Research and Treatments 8
- Acute Myeloid Leukemia Research 4
- Oncology 17
- CAR-T cell therapy research 10
- Cancer survivorship and care 3
- Vascular Tumors and Angiosarcomas 2
- Co-authors
- Raúl Calvo Córdoba (8 shared papers)Valentina Boni (2 shared papers)Víctor Moreno (4 shared papers)Claudia Merz (1 shared paper)Grzegorz S. Nowakowski (1 shared paper)Oliver Boix (1 shared paper)David Serrano (1 shared paper)Joan Gisbert Cid (1 shared paper)
- Journals
- HemaSphere (6 papers)Blood (3 papers)Cancer Medicine (1 paper)Transplantation and Cellular Therapy (1 paper)npj Precision Oncology (1 paper)
- Partner nations
- SpainUnited StatesNetherlands
In The Last Decade
Daniel Morillo Giles
27 papers receiving 318 citations
Daniel Morillo Giles's Hit Papers
Peers
Comparison fields: 5 of 41
- Hematology 135
- Oncology 104
- Genetics 32
- Immunology 56
- Radiology, Nuclear Medicine and Imaging 42
Countries citing papers authored by Daniel Morillo Giles
This map shows the geographic impact of Daniel Morillo Giles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Morillo Giles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Morillo Giles more than expected).
Fields of papers citing papers by Daniel Morillo Giles
This network shows the impact of papers produced by Daniel Morillo Giles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Morillo Giles. The network helps show where Daniel Morillo Giles may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Morillo Giles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma Hit paper breakdown → | 2025 | 69 |
| 2 | Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study Hit paper breakdown → | 2025 | 59 |
| 3 | 2022 | 36 | |
| 4 | 2018 | 32 | |
| 5 | 2014 | 27 | |
| 6 | 2021 | 17 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 11 | |
| 9 | 2023 | 10 | |
| 10 | 2020 | 10 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 7 | |
| 13 | 2022 | 3 | |
| 14 | 2025 | 2 | |
| 15 | 2025 | 2 | |
| 16 | 2016 | 2 | |
| 17 | 2023 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2025 | 1 |
About Daniel Morillo Giles
Daniel Morillo Giles is a scholar working on Hematology, Oncology, Genetics, Pathology and Forensic Medicine and Immunology, having authored 34 papers that have together received 322 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Lymphoma Diagnosis and Treatment (9 papers), Multiple Myeloma Research and Treatments (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Acute Myeloid Leukemia Research (4 papers), Cancer survivorship and care (3 papers), Vascular Tumors and Angiosarcomas (2 papers) and Cutaneous lymphoproliferative disorders research (2 papers). The work is most often cited by research in Hematology (135 citations), Oncology (104 citations), Genetics (32 citations), Immunology (56 citations) and Radiology, Nuclear Medicine and Imaging (42 citations). Daniel Morillo Giles has collaborated with scholars based in Spain, United States and Netherlands. Frequent co-authors include Raúl Calvo Córdoba, Valentina Boni, Víctor Moreno, Claudia Merz, Grzegorz S. Nowakowski, Oliver Boix, David Serrano, Joan Gisbert Cid, Joy M. Greer and Ana Maria Villegas. Their work appears in journals such as HemaSphere, Blood, Cancer Medicine, Transplantation and Cellular Therapy and npj Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.